Novo Nordisk

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Novo Nordisk and other ETFs, options, and stocks.

About NVO

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care and Rare Disease segments. 

CEO
Maziar Mike Doustdar
CEOMaziar Mike Doustdar
Employees
68,794
Employees68,794
Headquarters
Bagsværd, Capital Region
HeadquartersBagsværd, Capital Region
Founded
1923
Founded1923
Employees
68,794
Employees68,794

NVO Key Statistics

Market cap
167.26B
Market cap167.26B
Price-Earnings ratio
10.74
Price-Earnings ratio10.74
Dividend yield
3.29%
Dividend yield3.29%
Average volume
16.10M
Average volume16.10M
High today
$38.41
High today$38.41
Low today
$37.46
Low today$37.46
Open price
$38.30
Open price$38.30
Volume
7.87M
Volume7.87M
52 Week high
$81.44
52 Week high$81.44
52 Week low
$35.12
52 Week low$35.12

NVO News

TipRanks 1h
Novo Nordisk’s EVOKE Alzheimer’s Trial: What the Latest Update Means for NVO Investors

Novo Nordisk (NVO) announced an update on their ongoing clinical study. Unlock hedge fund-level data and powerful investing tools for smarter, sharper decision...

24/7 Wall St. 2h
Eli Lilly vs. Novo Nordisk: The Obesity Drug Race Has a New Leader

Eli Lilly vs. Novo Nordisk: The Obesity Drug Race Has a New Leader By Vandita Jadeja Published Apr 10, 12:09PM EDT Quick Read Eli Lilly (LLY) reported Q4 reve...

Eli Lilly vs. Novo Nordisk: The Obesity Drug Race Has a New Leader
24/7 Wall St. 6h
Who Benefits From Amazon Pharmacy Stocking Eli Lilly's New Weight Loss Pill

Who Benefits From Amazon Pharmacy Stocking Eli Lilly’s New Weight Loss Pill By Trey Thoelcke Published Apr 10, 8:25AM EDT Quick Read Amazon (AMZN) has made a...

Who Benefits From Amazon Pharmacy Stocking Eli Lilly's New Weight Loss Pill

Analyst ratings

61%

of 36 ratings
Buy
30.6%
Hold
61.1%
Sell
8.3%

More NVO News

MarketWatch 1d
Here’s how much weight-loss drugs Wegovy, Zepbound and Foundayo cost — and how to pick the best GLP-1 for you

Taking GLP-1s once meant injecting a shot with a monthly price tag of $1,000. Today, patients interested in the wildly popular weight-loss drugs can choose amon...

Here’s how much weight-loss drugs Wegovy, Zepbound and Foundayo cost — and how to pick the best GLP-1 for you
Benzinga 1d
Novo Nordisk Wins EU Nod To Ease Wegovy Injection Delivery

The decision marks a shift away from strict cold chain requirements and positions Wegovy as the first GLP-1 therapy in Europe with this level of delivery flexib...

Novo Nordisk Wins EU Nod To Ease Wegovy Injection Delivery
Seeking Alpha 1d
EU eases delivery requirement for Novo Nordisk’s Wegovy

The EU drug regulator, the European Medicines Agency (EMA) has eased a cold-chain requirement that Novo Nordisk’s (NVO) obesity injection, Wegovy, should be sub...

EU eases delivery requirement for Novo Nordisk’s Wegovy
Nasdaq 2d
Which of These Healthcare Stocks Is More Likely to Be a Millionaire Maker?

Key Points These two companies operate in a high-growth market, one that’s heading toward $100 billion, according to analysts’ forecasts. Their products have...

Which of These Healthcare Stocks Is More Likely to Be a Millionaire Maker?
Simply Wall St 2d
Hims & Hers Health Is Down 6.1% After Expanding GLP-1 Access With Novo Nordisk Collaboration

In late March 2026, Hims & Hers Health announced a renewed collaboration with Novo Nordisk, adding a broad range of FDA-approved GLP-1 medications, including We...

Hims & Hers Health Is Down 6.1% After Expanding GLP-1 Access With Novo Nordisk Collaboration
Simply Wall St 2d
Has Novo Nordisk Fallen Too Far After Recent Pharma Sector Headlines

If you are wondering whether Novo Nordisk's current share price lines up with its fundamentals, this article walks through the key valuation angles that matter...

Has Novo Nordisk Fallen Too Far After Recent Pharma Sector Headlines
MarketWatch 2d
A high dose of Wegovy will cost $50 less than Zepbound

Novo Nordisk has launched the high-dose version of its GLP-1 injection at a price that’s $50 lower than the one for Eli Lilly’s competing drug. For patients pa...

A high dose of Wegovy will cost $50 less than Zepbound

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.